The 140th Annual Meeting of the Pharmaceutical Society of Japan (Kyoto)
Advanced Search

Session Details

International Symposium

[IS02]FIP forum-Collaboration of pharmacists and pharmaceutical scientists in patient empowerment at global levels

Sat. Mar 28, 2020 1:45 PM - 3:45 PM JST
Sat. Mar 28, 2020 4:45 AM - 6:45 AM UTC
[Room A] Room A 2F
Organizer: Masaru Kato (Sch Pharm, Showa Univ)
Development and effective use of medicines have to be supported by the patients. To achieve this, patient empowerment should be considered in all scenes of pharmaceutical science and practice and scientists and pharmacists are ready to collaborate in these regards. International Pharmaceutical Federation (FIP), as the sole global pharmaceutical organization, strongly supports this movement. In the FIP forum, FIP president and representatives of four different stakeholders will summarize their roles and express their opinions.
They are: Mr. Dominique Jordan of FIP, Dr. Junko Sato of Pharmaceutical and Medical Device Agency, Ms. Laureline Gatellier, a patient advocacy, Dr. Yoshiaki Ohashi of Chugai Pharmaceutical, and Mr. Nobuo Yamamoto of Japan Pharmaceutical Association. Participants will become aware of the importance of patients' involvement in all aspects of pharmaceutical affairs.
1:45 PM - 1:47 PM JST(4:45 AM - 4:47 AM UTC)

[IS02-Introduction]Introduction

Tatsuro Irimura1 (1. Juntendo Univ)
1:47 PM - 2:17 PM JST(4:47 AM - 5:17 AM UTC)

[IS02-1]Together with patients and for patients

○Dominique Jordan1 (1. FIP)
2:17 PM - 2:42 PM JST(5:17 AM - 5:42 AM UTC)

[IS02-2]To promote patient-public engagement in Japan

○Junko Sato1 (1. PMDA)
2:42 PM - 2:54 PM JST(5:42 AM - 5:54 AM UTC)

[IS02-3]Drugs and pharmacists, lifetime partners – the patient perspective

○Laureline Gatellier1 (1. Japan Brain Tumor Alliance)
2:54 PM - 3:19 PM JST(5:54 AM - 6:19 AM UTC)

[IS02-4]Drug safety communication with a pharmaceutical company

○Yoshiaki Ohashi1 (1. Chugai Pharm)
3:19 PM - 3:44 PM JST(6:19 AM - 6:44 AM UTC)

[IS02-5]How can we contribute to integrated community care and UHC: Pharmacist’s viewpoint

○Nobuo Yamamoto1 (1. Japan Pharm Assoc)
3:44 PM - 3:45 PM JST(6:44 AM - 6:45 AM UTC)

[IS02-Closing]Closing remarks

Masaru Kato1 (1. Showa Univ)
Back to Category List